Medlander Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 550

Employees

  • Stock Symbol
  • 688273

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $3.88
  • (As of Friday Closing)

Medlander General Information

Description

Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales, and service of related products in the field of pelvic floor and postpartum rehabilitation. Its products mainly include: biostimulation feedback instrument, color ultrasound diagnosis and evaluation system, magnetic stimulator, high-frequency evaluation electrocautery instrument, pelvic floor training instrument, portable postpartum recovery instrument, home pelvic floor rehabilitation therapy instrument, etc., which are widely used in obstetrics and gynecology, pelvic floor rehabilitation center, urology, anorectal department and other hospital departments.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Building 5, Acceleration Zone Nanjing Life Science and Technology Innovation Park
  • Number 6 Qiande Road, 211100 Jiangning District
  • Nanjing, Jiangsu 211100
  • China
+86 025
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Outcome Management (Healthcare)
Stock Exchange
SHG
Corporate Office
  • Building 5, Acceleration Zone Nanjing Life Science and Technology Innovation Park
  • Number 6 Qiande Road, 211100 Jiangning District
  • Nanjing, Jiangsu 211100
  • China
+86 025

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medlander Stock Performance

As of 13-Nov-2026, Medlander’s stock price is $3.88. Its current market cap is $388M with 100M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.88 $3.97 $3.63 - $8.76 $388M 100M 1.12M $0.09

Medlander Financials Summary

As of 30-Sep-2026, Medlander has a trailing 12-month revenue of $55.5M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 340,698 499,666 201,353 320,862
Revenue 55,533 60,016 59,167 48,174
EBITDA 8,518 18,812 20,022 14,818
Net Income 9,243 14,271 14,157 12,695
Total Assets 233,420 232,862 211,863 216,393
Total Debt 3,247 4,797 2,124 1,200
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medlander Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medlander‘s full profile, request access.

Request a free trial

Medlander Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Medlander‘s full profile, request access.

Request a free trial

Medlander Patents

Medlander Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3342453-B1 Smart pelvic floor muscle rehabilitation training device Active 28-Aug-2015
EP-3342453-A1 Smart pelvic floor muscle rehabilitation training device and method for using the same Active 28-Aug-2015
EP-3342453-A4 Smart pelvic floor muscle rehabilitation training device and method for using the same Active 28-Aug-2015
WO-2017035951-A1 Smart pelvic floor muscle rehabilitation training device and method for using the same Inactive 28-Aug-2015 A61N1/36007

Medlander Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medlander Investments & Acquisitions (4)

Medlander’s most recent deal was a Later Stage VC with Gimay for . The deal was made on 04-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gimay 04-Jun-2026 Later Stage VC Electronics (B2C)
Zhimei Xingchen 03-Jun-2026 Early Stage VC Therapeutic Devices
Wrightin 24-May-2024 Merger/Acquisition Therapeutic Devices
Xiaofu Tech 26-Jan-2024 Merger/Acquisition Electronics (B2C)
To view Medlander’s complete investments and acquisitions history, request access »

Medlander ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Medlander’s complete esg history, request access »

Medlander Exits (1)

Medlander’s most recent exit was on 26-Jan-2024 from Xiaofu Tech. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Xiaofu Tech 26-Jan-2024 Completed
To view Medlander’s complete exits history, request access »

Medlander Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Wrightin Nanjing, China 2017

Medlander FAQs

  • When was Medlander founded?

    Medlander was founded in 2013.

  • Where is Medlander headquartered?

    Medlander is headquartered in Nanjing, China.

  • What is the size of Medlander?

    Medlander has 550 total employees.

  • What industry is Medlander in?

    Medlander’s primary industry is Diagnostic Equipment.

  • Is Medlander a private or public company?

    Medlander is a Public company.

  • What is Medlander’s stock symbol?

    The ticker symbol for Medlander is 688273.

  • What is the current stock price of Medlander?

    As of 13-Nov-2026 the stock price of Medlander is $3.88.

  • What is the current market cap of Medlander?

    The current market capitalization of Medlander is $388M.

  • What is Medlander’s current revenue?

    The trailing twelve month revenue for Medlander is $55.5M.

  • What is Medlander’s annual earnings per share (EPS)?

    Medlander’s EPS for 12 months was $0.09.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process